Report Summary
Eternity Insights has published a new study on Global Intravenous Solutions (Colloids) Market focusing on key segments as by Type (Peripheral Parenteral Nutrition,Total Parenteral Nutrition, Other), by Application (Hospital & Clinics,Ambulatory,Home Care, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Intravenous Solutions (Colloids) Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Intravenous Solutions (Colloids) Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Intravenous Solutions (Colloids) Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Intravenous Solutions (Colloids) Market Segmentation:
Intravenous Solutions (Colloids) Market, By Type
- Peripheral Parenteral Nutrition
- Total Parenteral Nutrition
- Other
Intravenous Solutions (Colloids) Market, By Application
- Hospital & Clinics
- Ambulatory
- Home Care
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Intravenous Solutions (Colloids) market in terms of demand generation. The Intravenous Solutions (Colloids) market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Intravenous Solutions (Colloids) market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Intravenous Solutions (Colloids) Market Taxonomy:
To learn more about this report
Global Intravenous Solutions (Colloids) Market Competitive Landscape
The global Intravenous Solutions (Colloids) market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- ICU Medical Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Baxter
- Amanta Healthcare
- Terumo Medical Corporation
- Grifols S.A.
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Peripheral Parenteral Nutrition,Total Parenteral Nutrition, Other |
| By Application Outlook |
Hospital & Clinics,Ambulatory,Home Care, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
ICU Medical Inc.,B. Braun Melsungen AG,Fresenius Kabi AG,Baxter,Amanta Healthcare,Terumo Medical Corporation,Grifols S.A. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Intravenous Solutions (Colloids) Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Intravenous Solutions (Colloids) Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Intravenous Solutions (Colloids) Industry Overview
2.1 Global Intravenous Solutions (Colloids) Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Intravenous Solutions (Colloids) Global Import Market Analysis
2.1.2 Intravenous Solutions (Colloids) Global Export Market Analysis
2.1.3 Intravenous Solutions (Colloids) Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Peripheral Parenteral Nutrition
2.2.2 Total Parenteral Nutrition
2.3.2 Ambulatory
2.3.3 Home Care
2.4.2 Global Intravenous Solutions (Colloids) Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Intravenous Solutions (Colloids) Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Intravenous Solutions (Colloids) Manufacturer Market Share
2.4.5 Top 10 Intravenous Solutions (Colloids) Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Intravenous Solutions (Colloids) Market
2.4.7 Key Manufacturers Intravenous Solutions (Colloids) Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Intravenous Solutions (Colloids) Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Intravenous Solutions (Colloids) Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Intravenous Solutions (Colloids) Market Size Categorized by Regions
4.1 Global Intravenous Solutions (Colloids) Revenue, Sales and Market Share by Regions
4.1.1 Global Intravenous Solutions (Colloids) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Intravenous Solutions (Colloids) Revenue and Market Share by Regions (2015-2020)
4.2 Europe Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
4.3 APAC Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
4.4 North America Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
4.5 South America Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
5 Europe Intravenous Solutions (Colloids) Market Size Categorized by Countries
5.1 Europe Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Countries
5.1.1 Europe Intravenous Solutions (Colloids) Sales by Countries (2015-2020)
5.1.2 Europe Intravenous Solutions (Colloids) Revenue by Countries (2015-2020)
5.1.3 Germany Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
5.1.4 UK Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
5.1.5 France Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
5.1.6 Russia Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
5.1.7 Italy Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
5.1.8 Spain Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
5.2 Europe Intravenous Solutions (Colloids) Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
5.3.2 Europe Intravenous Solutions (Colloids) Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
6 Asia-Pacific Intravenous Solutions (Colloids) Market Size Categorized by Countries
6.1 Asia-Pacific Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Intravenous Solutions (Colloids) Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Intravenous Solutions (Colloids) Revenue by Countries (2015-2020)
6.1.3 China Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
6.1.4 Japan Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
6.1.5 Korea Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
6.1.6 India Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
6.1.8 Australia Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Intravenous Solutions (Colloids) Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Intravenous Solutions (Colloids) Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Intravenous Solutions (Colloids) Sales and Market Share by Application (2015-2020)
7 North America Intravenous Solutions (Colloids) Market Size Categorized by Countries
7.1 North America Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Countries
7.1.1 North America Intravenous Solutions (Colloids) Sales by Countries (2015-2020)
7.1.2 North America Intravenous Solutions (Colloids) Revenue by Countries (2015-2020)
7.1.3 United States Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
7.1.4 Canada Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
7.1.5 Mexico Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
7.2 North America Intravenous Solutions (Colloids) Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
7.3.2 North America Intravenous Solutions (Colloids) Revenue and Revenue Share by Type (2015-2020)
7.4 North America Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
8 South America Intravenous Solutions (Colloids) Market Size Categorized by Countries
8.1 South America Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Countries
8.1.1 South America Intravenous Solutions (Colloids) Sales by Countries (2015-2020)
8.1.2 South America Intravenous Solutions (Colloids) Revenue by Countries (2015-2020)
8.1.3 Brazil Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
8.2 South America Intravenous Solutions (Colloids) Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
8.3.2 South America Intravenous Solutions (Colloids) Revenue and Revenue Share by Type (2015-2020)
8.4 South America Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
9 Middle East and Africa Intravenous Solutions (Colloids) Market Size Categorized by Countries
9.1 Middle East and Africa Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intravenous Solutions (Colloids) Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Intravenous Solutions (Colloids) Revenue by Countries (2015-2020)
9.1.3 GCC Countries Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
9.1.4 Turkey Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
9.1.5 Egypt Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
9.1.6 South Africa Intravenous Solutions (Colloids) Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Intravenous Solutions (Colloids) Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Intravenous Solutions (Colloids) Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Intravenous Solutions (Colloids) Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020)
10 Global Intravenous Solutions (Colloids) Market Segment by Type
10.1 Global Intravenous Solutions (Colloids) Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Intravenous Solutions (Colloids) Sales and Market Share by Type (2015-2020)
10.1.2 Global Intravenous Solutions (Colloids) Revenue and Market Share by Type (2015-2020)
10.2 Peripheral Parenteral Nutrition Sales Growth Rate and Price
10.2.1 Global Peripheral Parenteral Nutrition Sales Growth Rate (2015-2020)
10.2.2 Global Peripheral Parenteral Nutrition Price (2015-2020)
10.3 Total Parenteral Nutrition Sales Growth Rate and Price
10.3.1 Global Total Parenteral Nutrition Sales Growth Rate (2015-2020)
10.3.2 Global Total Parenteral Nutrition Price (2015-2020)
11.1 Global Intravenous Solutions (Colloids)Sales Market Share by Application (2015-2020)
11.2 Hospital & Clinics Sales Growth Rate (2015-2020)
11.3 Ambulatory Sales Growth Rate (2015-2020)
11.4 Home Care Sales Growth Rate (2015-2020)
12.1 Global Intravenous Solutions (Colloids) Revenue, Sales and Growth Rate (2020-2027)
12.2 Intravenous Solutions (Colloids) Market Forecast by Regions (2020-2027)
12.2.1 Europe Intravenous Solutions (Colloids) Market Forecast (2020-2027)
12.2.2 APAC Intravenous Solutions (Colloids) Market Forecast (2020-2027)
12.2.3 North America Intravenous Solutions (Colloids) Market Forecast (2020-2027)
12.2.4 South America Intravenous Solutions (Colloids) Market Forecast (2020-2027)
12.2.5 Middle East & Africa Intravenous Solutions (Colloids) Market Forecast (2020-2027)
12.3 Intravenous Solutions (Colloids) Market Forecast by Type (2020-2027)
12.3.1 Global Intravenous Solutions (Colloids) Sales Forecast by Type (2020-2027)
12.3.2 Global Intravenous Solutions (Colloids) Market Share Forecast by Type (2020-2027)
12.4 Intravenous Solutions (Colloids) Market Forecast by Application (2020-2027)
12.4.1 Global Intravenous Solutions (Colloids) Sales Forecast by Application (2020-2027)
12.4.2 Global Intravenous Solutions (Colloids) Market Share Forecast by Application (2020-2027)
13 Analysis of Intravenous Solutions (Colloids) Industry Key Manufacturers
13.1 ICU Medical Inc.
13.1.1 Company Details
13.1.2 Product Information
13.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 ICU Medical Inc. News
13.2 B. Braun Melsungen AG
13.2.1 Company Details
13.2.2 Product Information
13.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 B. Braun Melsungen AG News
13.3 Fresenius Kabi AG
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Fresenius Kabi AG News
13.4 Baxter
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Baxter Intravenous Solutions (Colloids) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Baxter News
13.5 Amanta Healthcare
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Amanta Healthcare News
13.6 Terumo Medical Corporation
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Terumo Medical Corporation News
13.7 Grifols S.A.
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Grifols S.A. Intravenous Solutions (Colloids) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Grifols S.A. News
15 Appendix
